Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Impact of Opioid Controlled Substance Agreements

Mayo Clin Proc; ePub 2018 Sep 20; Philpot, et al

Controlled substance agreement (CSA) enrollment was associated with reductions in primary care visits and increased radiologic service utilization in patients receiving long-term opioid therapy for chronic noncancer pain, a recent study found. Researchers retrospectively evaluated health care utilization changes among patients enrolled in a CSA between July 1, 2015, and December 31, 2015. Patient characteristics and utilization was assessed 12 months before and after CSA enrollment. They found:

  • 772 patients (mean age 63.5 years, mostly white, female, married) were enrolled in an opioid CSA during the study period.
  • CSA enrollment was associated with decreased outpatient primary care visits and increased diagnostic radiology services.
  • Patients with greater comorbidity were more likely to have reductions in hospitalization, outpatient primary care visits, and reduced specialty care visits.

Citation:

Philpot LM, Ramar P, Elrashidi MY, Sinclair TA, Ebbert JO. A before and after analysis of health care utilization by patients enrolled in opioid controlled substance agreements for chronic noncancer pain. [Published online ahead of print September 20, 2018]. Mayo Clin Proc. doi:10.1016/j.mayocp.2018.05.008.